Wonmet G1 Tablet PR is an advanced prescription medication formulated to provide strong, long-term management of blood glucose levels in adults with Type 2 Diabetes. It is typically recommended when treatment with a single medicine—especially Metformin alone—does not achieve sufficient glycemic control. This dual-action therapy works through two complementary mechanisms to effectively combat high blood sugar.

Glimepiride, a modern third-generation sulfonylurea, stimulates the pancreas to release natural insulin by activating specific receptors on the beta cells. This helps quickly reduce post-meal surges in blood sugar. Metformin, a widely trusted biguanide, takes a different approach. It primarily reduces the liver’s glucose production (gluconeogenesis) while also improving the body’s sensitivity to insulin, encouraging better glucose absorption and utilization in the muscles and fat tissues.

Together, these two components address the core issues of Type 2 Diabetes—insufficient insulin production and insulin resistance. By offering a balanced and synergistic effect, Wonmet G1 Tablet PR supports patients in achieving optimal HbA1c levels and lowering the risk of long-term complications affecting the heart, kidneys, nerves, and eyes.

For best results, it is important to follow your doctor’s dosage and instructions consistently, as Type 2 Diabetes is a chronic and progressive condition that requires continuous management.